Cargando…
Clinical validation of engineered CRISPR/Cas12a for rapid SARS-CoV-2 detection
BACKGROUND: The coronavirus disease (COVID-19) caused by SARS-CoV-2 has swept through the globe at an unprecedented rate. CRISPR-based detection technologies have emerged as a rapid and affordable platform that can shape the future of diagnostics. METHODS: We developed ENHANCEv2 that is composed of...
Autores principales: | Nguyen, Long T., Rananaware, Santosh R., Pizzano, Brianna L. M., Stone, Brandon T., Jain, Piyush K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053293/ https://www.ncbi.nlm.nih.gov/pubmed/35603267 http://dx.doi.org/10.1038/s43856-021-00066-4 |
Ejemplares similares
-
Programmable RNA detection with CRISPR-Cas12a
por: Rananaware, Santosh R., et al.
Publicado: (2023) -
Programmable RNA detection with CRISPR-Cas12a
por: Rananaware, Santosh R., et al.
Publicado: (2023) -
Programmable RNA detection with CRISPR-Cas12a
por: Rananaware, Santosh R., et al.
Publicado: (2023) -
A Thermostable Cas12b from
Brevibacillus
Leverages One-pot Detection of SARS-CoV-2 Variants of Concern
por: Nguyen, Long T., et al.
Publicado: (2021) -
Engineering highly thermostable Cas12b via de novo structural analyses for one-pot detection of nucleic acids
por: Nguyen, Long T., et al.
Publicado: (2023)